Lloyd Price

JULY 13, 2024

Exec Summary Danuglipron is an experimental weight loss medication being developed by Pfizer. It's important to remember that it is not currently approved for use by any health authority. Here's a breakdown of what we know so far: Type of Drug: Danuglipron belongs to a class of drugs called GLP-1 receptor agonists. These medications work by mimicking a natural hormone that helps regulate blood sugar and appetite.

Leadership 73

Leadership healthcare technology Digital Health Health IT 73

Healthcare IT Today

JULY 13, 2024

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week. Greenway CEO Sets Company on a Bold Path. Colin Hung caught up with Pratap Sarker to follow up on his promise from the company’s recent user group meeting that all future innovations from Greenway would be based on AI.

RCM 117

RCM Interoperability Healthcare IT FHIR 117